AdAlta $0.024
(0.00%)
|
High $0.03 |
Low $0.02 |
Trades 24 |
Turnover $54,432 |
Volume 2,170,184 |
| 30 June 2023 at 3:59pm | ||||
ADALTA LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $8,030,422 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
Final Director's Interest Notice
1AD released this announcement to the ASX on 24 March 2023, 9:54. The announcement is not marked as price sensitive, and is 4 page(s) in length and 213.39kb in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| Final Director's Interest Notice | 24 March 2023, 9:54 |
| Retirement of Non-Executive Director | 24 March 2023, 9:50 |
| ShareCafe webinar presentation 3 Mar 2023 | 2 March 2023, 8:17 |
| Half Yearly Report and Accounts | 27 February 2023, 17:53 |
If you were already registered, log in here.
If you were already registered, log in here.